Study With Phage for CF Subjects With Pseudomonas Lung Infection

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(14 sites)

United States

University of Alabama at Birmingham, Birmingham, Alabama

Providence Alaska Medical Center, Anchorage, Alaska

University of Arkansas for Medical Sciences, Little Rock, Arkansas

Stanford University, Palo Alto, California

University of California San Francisco, San Francisco, California

National Jewish Health, Denver, Colorado

Joe DiMaggio Children's Health, Hollywood, Florida

Central Florida Pulmonary Group, Orlando, Florida

Avanza Medical Center, Pensacola, Florida

Rutgers, Robert Wood Johnson Medical School, New Brunswick, New Jersey

New York Medical College, Hawthorne, New York

Northwell Health, New York, New York

Vanderbilt University Medical Center, Nashville, Tennessee

University of Utah, Salt Lake City, Utah